Clinical Trial Update: Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the SOX regimen (S-1 plus oxaliplatin) for biliary tract cancer, including ampullary adenocarcinoma; sponsor listed as Peking Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Adenocarcinoma
• Biliary Tract Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN